VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells
VMY-1-103 是一种新型 CDK 抑制剂，它能破坏髓母细胞瘤细胞的染色体结构并延缓中期进程。
期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.4161/cbt.12.9.17682
Ringer, Lymor; Sirajuddin, Paul; Heckler, Mary; Ghosh, Anup; Suprynowicz, Frank; Yenugonda, Venkata M; Brown, Milton L; Toretsky, Jeffrey A; Uren, Aykut; Lee, YiChien; MacDonald, Tobey J; Rodriguez, Olga; Glazer, Robert I; Schlegel, Richard; Albanese, Chris
